Wells Fargo’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Sell
33,237
-75,294
-69% -$625K ﹤0.01% 4692
2025
Q4
$1.13M Sell
108,531
-3,397
-3% -$34.1K ﹤0.01% 3870
2025
Q3
$1.01M Sell
111,928
-8,559
-7% -$75.1K ﹤0.01% 3817
2025
Q2
$1.57M Buy
120,487
+92,883
+336% +$1.4M ﹤0.01% 3398
2025
Q1
$697K Buy
27,604
+1,030
+4% +$30.6K ﹤0.01% 3862
2024
Q4
$914K Buy
26,574
+445
+2% +$20.1K ﹤0.01% 3773
2024
Q3
$1.29M Sell
26,129
-21,926
-46% -$1.12M ﹤0.01% 3373
2024
Q2
$2.89M Buy
48,055
+12,138
+34% +$694K ﹤0.01% 2687
2024
Q1
$1.85M Buy
35,917
+11,191
+45% +$549K ﹤0.01% 3029
2023
Q4
$997K Sell
24,726
-1,662
-6% -$48.7K ﹤0.01% 3431
2023
Q3
$736K Sell
26,388
-1,788
-6% -$53.3K ﹤0.01% 3532
2023
Q2
$811K Buy
28,176
+9,199
+48% +$205K ﹤0.01% 3611
2023
Q1
$317K Buy
18,977
+5,517
+41% +$77.9K ﹤0.01% 4148
2022
Q4
$171K Sell
13,460
-4,993
-27% -$60.7K ﹤0.01% 4263
2022
Q3
$222K Sell
18,453
-4,138
-18% -$56.8K ﹤0.01% 4187
2022
Q2
$318K Sell
22,591
-12,900
-36% -$170K ﹤0.01% 4020
2022
Q1
$440K Buy
35,491
+1,843
+5% +$22.1K ﹤0.01% 4503
2021
Q4
$379K Buy
33,648
+7,259
+28% +$87.2K ﹤0.01% 4886
2021
Q3
$334K Buy
+26,389
New +$363K ﹤0.01% 4883

Other funds holding RXST

Wells Fargo's RXST Position: Q1 2026 in Review

Wells Fargo reduced its RxSight (RXST) stake by 69% in Q1 2026, selling an estimated $625K and leaving 33,237 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #4692.

Wells Fargo first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.89M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Wells Fargo held 33,237 shares of RxSight worth $205K as of Q1 2026.
  • Wells Fargo sold 75,294 RxSight shares in Q1 2026, an estimated $625K.
  • RxSight made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4692 holding.
  • Wells Fargo first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
  • Wells Fargo's RxSight position peaked at $2.89M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.